RxSight, Inc. (NASDAQ:RXST) Q4 2023 Earnings Conference Call February 28, 2024 4:30 PM ET
Company Participants
Oliver Moravcevic - Vice President, Investor Relations
Ron Kurtz - President and Chief Executive Officer
Shelley Thunen - Assistant Secretary and Chief Financial Officer
Conference Call Participants
Steven Lichtman - Oppenheimer
Robbie Marcus - JPMorgan
Simran Kaur - Wells Fargo
Ryan Zimmerman - BTIG
Craig Bijou - Bank of America
Patrick Wood - Morgan Stanley
Thomas Stephan - Stifel
David Saxon - Needham and Company
Operator
Good day and thank you for standing by. Welcome to the RxSight Fourth Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your first speaker today, Oliver Moravcevic, please go ahead.
Oliver Moravcevic
Thank you, operator. Presenting today are RxSight President and Chief Executive Officer, Ron Kurtz; and Chief Financial Officer, Shelley Thunen. Earlier today, RxSight released financial results for the three-month and full-year ended December 31st, 2023. A copy of the press release is available on the company's website.
Before we begin, I would like to inform you that comments and responses to your questions during today's call reflect management's views as of today, February 28th, 2024, and will include forward-looking and opinion statements, including predictions, estimates, plans, expectations, and other information.
Actual results may differ materially from those expressed or implied as a result of certain risks and uncertainties. These risks and uncertainties are more fully described in our press release issued earlier today and in our filings with the Securities and Exchange Commission or SEC.
Our SEC filings can be found on our website or on the SEC's website. Investors are cautioned not to place undue reliance on forward-looking statements. We disclaim any obligation to update or revise these forward-looking statements.
We will also discuss certain non-GAAP financial measures. Disclosures regarding these non-GAAP financial measures, including reconciliations to the most comparable GAAP measures, can be found in the press release. Please note that this conference call will be available for audio replay on our investor website.
With that, I will turn the call over to our President and CEO, Dr. Ron Kurtz. Ron?
Ron Kurtz
Good afternoon and thank you for joining us. In a moment, Shelley will be giving an update on RxSight's financial performance for both Q4 and full year 2023.